Prostate Health



Oncology Radiation Oncology Urology



Prostate Health


Cancer Programs Radiation Oncology Urology

Prostate Cancer Statistics

These statistics are from information published by the Surveillance, Epidemiology, and End Results (SEER) Program, a continuing project of the National Cancer Institute (NCI).

The SEER Program collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.

Goals of the SEER Program include:

> Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States.

> Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics.

> Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival.

> Promoting studies designed to identify factors amenable to cancer control interventions, such as:

a) environmental, occupational, socioeconomic, dietary, and health-related exposures

b) screening practices, early detection, and treatment

c) determinants of the length and quality of patient survival

Statistics on prostate cancer:

Consider the following statistics related to prostate cancer:

Prostate cancer is the most common cancer among men, excluding skin cancer.
American Cancer Society (ACS) estimates for 2005 include 232,000 new cases of prostate cancer in the US.
Year 2005 estimates include 30,350 deaths occurring from prostate cancer in the US alone, making it the second leading cause of cancer death in men.
All men are at risk for prostate cancer. The risk increases with age, and family history also increases the risk.
African-American men have about a 60 percent higher incidence rate of prostate cancer than Caucasian men, and nearly a two-fold higher mortality rate than Caucasian men.

Click here to view the
Online Resources page of this Web.

Cancer Care at Rush

When it comes to treating cancer, experience matters. And Rush University Medical Center in Chicago, Illinois, has it, with one of the Midwest’s largest and most comprehensive cancer treatment programs, combining leading-edge therapies with vital emotional support.

For more information, visit the Cancer Programs home page.

Looking for Other Health Information?

Visit our Health Information home page.

or

Visit Discover Rush’s Web Resource page to find articles on health topics and recent health news from Rush University Medical Center in Chicago, Illinois. You will also find many helpful links to other areas of our site.

Looking for a Doctor?

Rush University Medical Center in Chicago, Illinois, is a leader in caring for people of all ages, from newborns through older adults.

Just phone (888) 352-RUSH or (888) 352-7874 for help finding the Rush doctor who’s right for you.



Prostate Cancer Prostate Health Home Page Prostate Cancer Statistics